Credit rating agency, India Rating & Research has affirmed India - based Claris Lifesciences’ Long Term issuer rating at ‘A-’ on Rating Watch Positive (RWP). This reflects the significant improvement in the company’s Credit profile and improvement in credit metrics.
Claris Lifesciences has recently received the long awaited USFDA approval for its manufacturing facility. The company now has nine ANDAs approved in its name across four molecules. The company has a total filing of 30 ANDAs across 20 products.
| Company Name | CMP |
|---|---|
| Redington | 280.90 |
| Amrapali Industries | 42.31 |
| Adani Enterprises | 3037.90 |
| Rashi Peripheral | 752.80 |
| PDS | 338.40 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: